PPT-Crysvita ® ( burosumab-twza
A Summary of Clinical Trial Data MRCPKRN2300318 518 Crysvita Overview Indications and Usage Crysvita is a fibroblast growth factor 23 FGF23 blocking antibody indicated
Download Presentation
"Crysvita ® ( burosumab-twza" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.